WYYMEDIUM SIGNALFINANCIAL10-K

WidePoint's operating losses deepened meaningfully while the company maintained stronger cash reserves, suggesting continued profitability challenges despite improved liquidity.

The company's operating losses expanded substantially year-over-year, indicating ongoing operational efficiency challenges that investors should monitor closely. However, the notable increase in cash position to $9.8M provides improved financial flexibility to weather near-term headwinds and invest in growth initiatives.

Comparing 2026-03-25 vs 2025-04-15View on EDGAR →
FINANCIAL ANALYSIS

WidePoint's balance sheet showed mixed signals, with cash reserves growing notably to $9.8M and receivables expanding 25.7%, suggesting increased business activity. However, current liabilities rose 20.9% and stockholders' equity declined 15.1%, while operating losses deepened substantially from the prior year. The overall picture reflects a company generating more revenue activity but struggling with operational efficiency and profitability execution.

FINANCIAL STATEMENT CHANGES
Total Debt
Balance Sheet
+48.5%
$334K$496K

Debt increased 48.5% — substantial leverage increase; assess whether deployed for growth or covering losses.

Operating Income
P&L
-48.1%
-$1.9M-$2.8M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Cash & Equivalents
Balance Sheet
+44.9%
$6.8M$9.8M

Cash position surged 44.9% — strong cash generation or capital raise providing significant financial cushion.

Net Income
P&L
-42.2%
-$1.9M-$2.8M

Net income declined 42.2% — review whether driven by operations, interest costs, or non-recurring items.

Accounts Receivable
Balance Sheet
+25.7%
$11.9M$15.0M

Receivables grew 25.7% — monitor days sales outstanding for collection efficiency.

Current Liabilities
Balance Sheet
+20.9%
$52.9M$63.9M

Current liabilities rose 20.9% — increased short-term obligations, watch current ratio.

Current Assets
Balance Sheet
+19.7%
$55.3M$66.2M

Current assets grew 19.7% — improving short-term liquidity or inventory/receivables build.

Total Liabilities
Balance Sheet
+17.7%
$58.0M$68.3M

Liabilities increased 17.7% — monitor debt-to-equity ratio and interest coverage.

Stockholders Equity
Balance Sheet
-15.1%
$13.6M$11.5M

Equity decreased 15.1% — buybacks or losses reducing book value, monitor solvency ratios.

Total Assets
Balance Sheet
+11.5%
$71.6M$79.8M

Asset base grew 11.5% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-03-25
PRIOR — 2025-04-15
ADDED
As of March 19, 2026, there were 9,872,661 shares of the registrant s Common Stock issued and outstanding.
This contract represents a significant portion of our revenue.
Tariffs, inflationary pressures, and other macroeconomic forces that impact costs, such as costs for devices, labor and distribution costs may impact our financial condition or results of operations.
Federal government organizational changes and/or restructuring may pose unknown risks to WidePoint.
Changes in Federal Departmental leadership may result in changes priorities and changes in budgets can negatively impact our ability to maintain and/or grow revenue.
+7 more — sign up free →
REMOVED
As of March 31, 2025, there were 9,783,591 shares of the registrant s Common Stock issued and outstanding.
Inflationary pressures on costs, such as costs for devices, labor and distribution costs may impact our financial condition or results of operations.
The loss of significant federal customer contracts could also have an adverse impact on our financial results.
Federal government s current efforts to eliminate fraud waste and abuse could pose unknown risks to WidePoint.
Risks such as shutting down of whole agencies or departments we serve could negatively impact WidePoint s ability to maintain and/or grow revenue.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →